| Literature DB >> 27174997 |
Kai Zhou1, Qi Zhong1, Yan-Chun Wang1, Xiao-Yi Xiong1, Zhao-You Meng1, Ting Zhao1, Wen-Yao Zhu1, Mao-Fan Liao1, Li-Rong Wu1, Yuan-Rui Yang1, Juan Liu1, Chun-Mei Duan1, Jie Li1, Qiu-Wen Gong1, Liang Liu1, Mei-Hua Yang1, Ao Xiong2, Jian Wang3, Qing-Wu Yang1.
Abstract
Inflammation mediated by the peripheral infiltration of inflammatory cells plays an important role in intracerebral hemorrhage (ICH) induced secondary injury. Previous studies have indicated that regulatory T lymphocytes (Tregs) might reduce ICH-induced inflammation, but the precise mechanisms that contribute to ICH-induced inflammatory injury remain unclear. Our results show that the number of Tregs in the brain increases after ICH. Inducing Tregs deletion using a CD25 antibody or Foxp3DTR-mice increased neurological deficient scores (NDS), the level of inflammatory factors, hematoma volumes, and neuronal degeneration. Meanwhile, boosting Tregs using a CD28 super-agonist antibody reduced the inflammatory injury. Furthermore, Tregs depletion shifted microglia/macrophage polarization toward the M1 phenotype while boosting Tregs shifted this transition toward the M2 phenotype. In vitro, a transwell co-culture model of microglia and Tregs indicated that Tregs changed the polarization of microglia, decreased the expression of MHC-II, IL-6, and TNF-α and increased CD206 expression. IL-10 originating from Tregs mediated the microglia polarization by increasing the expression of Glycogen Synthase Kinase 3 beta (GSK3β), which phosphorylates and inactivates Phosphatase and Tensin homologue (PTEN) in microglia, TGF-β did not participate in this conversion. Thus, Tregs ameliorated ICH-induced inflammatory injury by modulating microglia/macrophage polarization toward the M2 phenotype through the IL-10/GSK3β/PTEN axis.Entities:
Keywords: Intracerebral hemorrhage; T-cells; inflammation; macrophages; microglia
Mesh:
Substances:
Year: 2016 PMID: 27174997 PMCID: PMC5363473 DOI: 10.1177/0271678X16648712
Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN: 0271-678X Impact factor: 6.200